Burden of Illness of Type 2 Diabetes Mellitus in the Kingdom of Saudi Arabia: A Five-Year Longitudinal Study

Mohammed AlHarbi,Abdullah Othman,Ahmed Ali Nahari,Ahmed Hamdan Al-Jedai,Daniel Cuadras,Faisal Almalky,Fayez AlAzmi,Hajer Yousef Almudaiheem,Hamad AlShubrumi,Hameed AlSwat,Homaid AlSahafi,Kamelia Sindi,Khadija Basaikh,Majed AlQahtani,Mark Lamotte,Moataz Yahia,Mohamed El-Khedr Hassan,Mohammed AlMutlaq,Mohammed AlRoaly,Somaya AlZelaye,Zein AlGhamdi
DOI: https://doi.org/10.1007/s12325-023-02772-y
2024-01-20
Advances in Therapy
Abstract:Type 2 diabetes mellitus (T2DM) is associated with huge clinical and economic burden in the Kingdom of Saudi Arabia (KSA) which can be curtailed by efficacious treatment. In order to achieve this, current treatment pathways for T2DM and associated costs need to be assessed.
pharmacology & pharmacy,medicine, research & experimental
What problem does this paper attempt to address?